Dermata Therapeutics Inc
NASDAQ:DRMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
Grid Metals Corp
XTSX:GRDM
|
CA |
|
Spindex Industries Ltd
SGX:564
|
SG |
|
A
|
Attica Bank SA
ATHEX:TATT
|
GR |
|
S
|
Sunway International Holdings Ltd
HKEX:58
|
HK |
|
F
|
Frontline Ltd
NYSE:FRO
|
BM |
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XETRA:MUV2
|
DE |
|
CLSA Premium Ltd
HKEX:6877
|
HK |
|
Indian Hume Pipe Company Ltd
NSE:INDIANHUME
|
IN |
|
E
|
EPIC Acquisition Corp
AEX:EPIC
|
UK |
|
A
|
Ads Maritime Holding Plc
OSE:ADS
|
NO |
|
C
|
Cheerwin Group Ltd
HKEX:6601
|
CN |
|
R
|
Rich Sparkle Holdings Ltd
NASDAQ:ANPA
|
HK |
Cash Flow Statement
Cash Flow Statement
Dermata Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(8)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(11)
|
(10)
|
(9)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(1)
|
(0)
|
1
|
0
|
1
|
1
|
0
|
1
|
(1)
|
(1)
|
(0)
|
|
| Cash from Operating Activities |
(4)
N/A
|
(3)
+15%
|
(4)
-5%
|
(4)
-23%
|
(6)
-29%
|
(8)
-32%
|
(8)
-12%
|
(9)
-4%
|
(9)
0%
|
(8)
+11%
|
(8)
0%
|
(7)
+10%
|
(6)
+10%
|
(7)
-16%
|
(8)
-4%
|
(9)
-21%
|
(11)
-19%
|
(10)
+7%
|
(11)
-5%
|
(9)
+15%
|
(8)
+17%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
1
|
1
|
15
|
15
|
14
|
19
|
4
|
4
|
8
|
6
|
6
|
8
|
3
|
4
|
9
|
7
|
15
|
12
|
8
|
12
|
|
| Net Issuance of Debt |
2
|
3
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
3
N/A
|
4
+61%
|
3
-21%
|
16
+397%
|
16
-2%
|
14
-10%
|
19
+30%
|
4
-77%
|
4
+0%
|
8
+98%
|
6
-33%
|
6
-1%
|
8
+35%
|
3
-55%
|
4
+24%
|
9
+109%
|
7
-23%
|
15
+123%
|
12
-19%
|
8
-37%
|
12
+54%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
(1)
N/A
|
1
N/A
|
(0)
N/A
|
12
N/A
|
10
-13%
|
7
-33%
|
10
+49%
|
(5)
N/A
|
(5)
0%
|
1
N/A
|
(2)
N/A
|
(1)
+34%
|
1
N/A
|
(4)
N/A
|
(3)
+13%
|
(0)
+86%
|
(4)
-777%
|
5
N/A
|
2
-69%
|
(1)
N/A
|
4
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(4)
N/A
|
(3)
+15%
|
(4)
-5%
|
(4)
-23%
|
(6)
-29%
|
(8)
-32%
|
(8)
-12%
|
(9)
-4%
|
(9)
0%
|
(8)
+11%
|
(8)
0%
|
(7)
+10%
|
(6)
+10%
|
(7)
-16%
|
(8)
-4%
|
(9)
-21%
|
(11)
-19%
|
(10)
+7%
|
(11)
-5%
|
(9)
+15%
|
(8)
+17%
|
|